Definiens Immunoprofiling Panel

Definiens has launched its Immunoprofiling panel, which allows researchers to rapidly screen tissue samples for immune responses. The panel uses biomarkers within tumors to measure immune response. Currently, the panel includes biomarkers PD-1, PD-L1, OX40, CTLA-4, CD3, CD4, CD8, CD20, CD68, CD163, and FoxP3.